Combating coronavirus: WHO suspends the trial of chloriquine treatment

Top Stories

Combating coronavirus, covid19, WHO, suspends, trial of chloriquine treatment

A study in the Lancet indicates that using the drug on Covid-19 patients could increase their likelihood of dying.

By AFP

  • Follow us on
  • google-news
  • whatsapp
  • telegram

Published: Tue 26 May 2020, 1:00 AM

Last updated: Tue 26 May 2020, 11:38 AM

The World Health Organisation said on Monday it had "temporarily" suspended clinical trials of hydroxychloriquine as a potential treatment for Covid-19 being carried out across a range of countries as a precautionary measure.
The decision came after the publication last week of a study in the Lancet indicating that using the drug on Covid-19 patients could increase their likelihood of dying, WHO chief Tedros Adhanom Ghebreyesus told a virtual press conference.
Tedros said that the executive group of the so-called Solidarity Trial, in which hundreds of hospitals across several countries have enrolled patients to test several possible treatments for the novel coronavirus, had as a precaution suspended trials using that drug.
 


More news from